Related Experiment Videos
Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings
Z Kahán1, I Tóth, M Vecsernyés
1Department of Radiology, A. Szent-Györgyi Medical University, Szeged, Hungary.
Oncology
|January 1, 1992
Abstract:
Eleven postmenopausal patients with advanced breast cancer were assessed for their response and endocrine changes to low-dose aminoglutethimide (250 mg twice a day) therapy without steroid administration. In 7 cases an objective response was registered; 1 patient had a stabilization of the disease lasting for 9 months. Significant falls in plasma estrogen and rises in plasma androgen levels were observed, while those of cortisol and ACTH remained essentially unchanged. No serious side effects occurred.